The Centre for In Vivo Modelling is a newly established research centre within the Division of Cancer Biology at the ICR. Our scientists and clinical researchers use state-of-the-art in vivo models to ...

Experts at The Institute of Cancer Research, London, have hailed findings from a major international trial showing that a personalised cancer vaccine can significantly reduce the risk of melanoma ...

Scientists have identified the genetic blueprints of 18 previously unknown bacterial species in DNA samples from people with prostate cancer. The study, led by researchers at the University of East ...

New research has pinpointed key stages in women's lives when lifestyle changes could have the greatest impact on reducing breast cancer risk. Previous research has shown that around a quarter of ...

Researchers have demonstrated that a streamlined genetic testing approach could identify more people with inherited breast cancer risk, while reducing the burden on NHS breast and genetic services.

The Institute of Cancer Research, London, works closely with trusts, foundations and charity partners who play an important part in enabling our state-of-the-art research. We recently marked a ...

Tens of thousands of tumour samples which have been stored in the basement of a London hospital for more than 70 years could be the key to unlocking the mystery of why bowel cancer cases are rising in ...

Thousands of men with prostate cancer in England will be offered a more precise form of radiotherapy that cuts treatment time by up to 75 per cent, based on the results of a trial led by The Institute ...

A targeted cancer treatment given via a simple injection under the skin shrank tumours in more than one third of patients with recurrent and/or metastatic head and neck cancer whose disease has ...

A drug currently being tested in clinical trials for a rare blood cancer could also be used to treat lobular breast cancer, according to a study published in the journal Cancer Research. Scientists at ...

The National Institute for Health and Care Excellence (NICE) criteria used to decide who should be referred by GPs for further breast cancer risk assessment and specialist care misses up to 95 per ...

A team co-led by researchers at The Institute of Cancer Research, London, has uncovered how treatment-resistant cancer cells may drive poor outcomes for people with triple-negative breast cancer (TNBC ...